Eisaku Nakamura
Director/Board Member chez KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Profil
Eisaku Nakamura is currently an Independent Outside Director at D.
Western Therapeutics Institute, Inc. and Kubota Pharmaceutical Holdings Co. Ltd.
He is also an Auditor at KOINOBORI Associate, Inc. In the past, he worked as a Director at Acucela, Inc.
Postes actifs de Eisaku Nakamura
| Sociétés | Poste | Début |
|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Board Member | 01/03/2016 |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Director/Board Member | 29/03/2018 |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 01/01/2017 |
Anciens postes connus de Eisaku Nakamura
| Sociétés | Poste | Fin |
|---|---|---|
| ACUCELA INC | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
